Literature DB >> 6173667

Analysis of (2'-5')-oligo(A) and related oligonucleotides by high-performance liquid chromatography.

R E Brown, P J Cayley, I M Kerr.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6173667     DOI: 10.1016/s0076-6879(81)79031-1

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  7 in total

1.  Immunological evidence for the in vivo occurrence of (2'-5')adenylyladenosine oligonucleotides in eukaryotes and prokaryotes.

Authors:  L Laurence; J Marti; D Roux; H Cailla
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

2.  Activation of 2',5'-oligoadenylate synthetase activity on induction of HL-60 leukemia cell differentiation.

Authors:  E L Schwartz; L A Nilson
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

3.  Inverse relationship between poly (ADP-ribose) polymerase activity and 2',5'-oligoadenylates core level in estrogen-treated immature rat.

Authors:  H Suzuki; D Tornese Buonamassa; A Weisz
Journal:  Mol Cell Biochem       Date:  1990-12-03       Impact factor: 3.396

4.  Novel 2',5'-oligoadenylates synthesized in interferon-treated, vaccinia virus-infected cells.

Authors:  A P Rice; S M Kerr; W K Roberts; R E Brown; I M Kerr
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

5.  2',5'-Oligoadenylate-dependent RNAse located in nuclei: biochemical characterization and subcellular distribution of the nuclease in human and murine cells.

Authors:  B A Bayard; J B Gabrion
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

6.  Analogue inhibitor of 2-5A action: effect on the interferon-mediated inhibition of encephalomyocarditis virus replication.

Authors:  D Watling; H T Serafinowska; C B Reese; I M Kerr
Journal:  EMBO J       Date:  1985-02       Impact factor: 11.598

Review 7.  The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.

Authors:  M R Player; P F Torrence
Journal:  Pharmacol Ther       Date:  1998-05       Impact factor: 12.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.